STOCKRETAIL-DRUG STORES AND PROPRIETARY STORESUpdated 2026-07-26
Here’s whether CVS HEALTH CORPORATION (CVS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.35% over 10 days); strong 1-year return of +83.4%; 3-month momentum positive (+38.2%). Currently 2.7% off its 52-week high. Score: +6/7.
CVS is in a confirmed uptrend, trading above both its 50-day ($100.09) and 200-day ($83.85) moving averages. An RSI of 66.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +83.4% compares to +16.5% for SPY (beat the market by 66.9%).
$10,000 invested 1 year ago→ $18,339 today
vs. S&P 500 (SPY) — same period beat market by 66.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($83.85)
✓Above 50-day MA ($100.09)
✓RSI(14) neutral zone (30–70) — currently 66.7
✓Positive return (+83.4%)
✓Within 10% of period high (−2.7%)
Period Range $107.74
$58.50$110.68
RSI (14) 66.7
0 · OversoldOverbought · 100
Key Metrics
Price$107.74
Period Return+83.4%
Period High$110.68
Period Low$58.50
Drawdown−2.7%
MA-50$100.09
MA-200$83.85
RSI (14)66.7
Avg Volume (30d)8.2M
vs. SPYbeat by 66.9%
Return Rank#131 of 999
Trend Signals
Price is above the 200-day moving average ($83.85)
Price is above the 50-day moving average ($100.09)